Federal regulators hold closed-door talks on clinical AI adoption

HHS, FDA, and ONC officials convene private meetings with industry to accelerate AI use in healthcare settings. Federal health officials from HHS, FDA, and ONC have initiated a series of closed-door meetings with technology companies, researchers, and lobbyists focused on accelerating the...